Materias dentro de su búsqueda.
Mostrando 1,401 - 1,420 Resultados de 5,148 Para Buscar '"Ph.D"', tiempo de consulta: 0.42s Limitar resultados
  1. 1401
    “…DISCLOSURES: Sarah McLeod, PhD, Innoviva Specialty Therapeutics: Employee|Innoviva Specialty Therapeutics: Employee|Innoviva Specialty Therapeutics: Stocks/Bonds|Innoviva Specialty Therapeutics: Stocks/Bonds Nicole Carter, MS, Innoviva Specialty Therapeutics: Employee|Innoviva Specialty Therapeutics: Stocks/Bonds Samir Moussa, PhD, Innoviva: Stocks/Bonds|Innoviva Specialty Therapeutics: Employee|Innoviva Specialty Therapeutics: Stocks/Bonds Alita Miller, PhD, Entasis Therapeutics: employee|Entasis Therapeutics: Stocks/Bonds…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2138. In Vitro Susceptibility of Recent Clinical Isolates of P. aeruginosa and Enterobacterales to Imipenem or Meropenem Alone or in Combination with Sulbactam-Durlobactam
  2. 1402
    “…DISCLOSURES: Mark G Wise, PhD, Merck & Co., Inc.: Honoraria|Pfizer Inc.: Honoraria|Venatorx: Paid fees for conducting the study and abstract preparation Meredith Hackel, PhD, Pfizer Inc.: Honoraria|Venatorx: Paid fees for conducting the study and abstract preparation Daniel F. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2150. In Vitro Activity of Cefepime-Taniborbactam and Comparators Against Genotypically Characterized Carbapenem-Resistant Enterobacterales (CRE) and Carbapenem-Resistant Pseudomonas aeruginosa (CRPA) from the United States, 2018-2021
  3. 1403
    “…Martin, PhD, MPH, Merck: Grant/Research Support Arnold Monto, MD, Roche: Advisor/Consultant|Roche: Honoraria Joshua Petrie, PhD, CSL Seqirus: Grant/Research Support…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    302. Investigating NAI Titer as a Neutralizing IAV Correlate of Protection
  4. 1404
    “…DISCLOSURES: Gitzinger Marc, PhD, BioVersys AG: Ownership Interest Christian Kemmer, PhD, BioVersys AG: Ownership Interest Lisa Husband, MBBS BSc MRCPCH, BioVersys AG: Ownership Interest Glenn Dale, PhD, BioVersys AG: Ownership Interest…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2544. Population pharmacokinetic meta-analysis of BV100 in healthy subjects and renally impaired subjects
  5. 1405
    “…DISCLOSURES: Mark G Wise, PhD, Merck & Co., Inc.: Honoraria|Pfizer Inc.: Honoraria|Venatorx: Paid fees for conducting the study and abstract preparation Gregory Stone, PhD, Pfizer: Stocks/Bonds Daniel F. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2151. In Vitro Activity of Ceftazidime-Avibactam and Comparator Agents Against Pseudomonas aeruginosa Collected from Patients with Presumed Hospital- and Community-Acquired Respiratory Tract Infections: ATLAS Global Surveillance Program, 2017-2021
  6. 1406
    “…[Figure: see text] DISCLOSURES: Austin Davis-Richardson, PhD, Invitae: Employee|One Codex: employee Petras Zdanavicius, MS, Invitae: employee|One Codex: employee Timothy Reynolds, PhD, Invitae: Employee|One Codex: employee Shawn Hawken, PhD, MPH, Invitae: employee|One Codex: employee…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2467. Automated Genomic Healthcare Epidemiology with One Codex
  7. 1407
    “…Inc: Grant/Research Support Diana Teloian, MA, Merck & Co., Inc: Grant/Research Support Engels N. Obi, PhD, Merck & Co Inc: Employee Joe Yang, PhD, Merck & Co., Inc: Employee|Merck & Co., Inc: Stocks/Bonds…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2814. The Impact of Novel Antibiotics on Curbing Antimicrobial Resistance and Infection Spread a Dynamic Modeling Study
  8. 1408
    “…Snyder, Ph.D., T2 Biosystems, Inc.: Stocks/Bonds Heather Noucas, MS, T2 Biosystems, Inc.: Stocks/Bonds Roger Smith, Ph.D., T2 Biosystems, Inc.: Stocks/Bonds…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    600. Rapid Detection of Antibiotic Resistance Genes Direct from Whole Blood Samples by T2 Magnetic Resonance (T2MR(®))
  9. 1409
    “…DISCLOSURES: Meredith Hackel, PhD, Pfizer Inc.: Honoraria|Venatorx: Paid fees for conducting the study and abstract preparation Gregory Stone, PhD, Pfizer: Stocks/Bonds Daniel F. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2128. In Vitro Activity of Ceftibuten-Avibactam and Comparator Agents Against Resistant Enterobacterales from UTIs Collected Globally as Part of the ATLAS Surveillance Program, 2022
  10. 1410
    “…DISCLOSURES: Raymond Farkouh, PhD, Pfizer (Employee) Arianna Nevo, MPH, Pfizer, Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1384. Conceptual Economic Model Methodology for Infant Pneumococcal Conjugate Vaccine Program and its Impact on Antimicrobial Resistance
  11. 1411
    “…Carrothers, ScD, AbbVie (Employee) H. Maxime Lagraauw, PhD, qPharmetra (Employee) Lars Lindbom, PhD, qPharmetra (Employee) Todd Riccobene, PhD, AbbVie (Employee)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1321. Population Pharmacokinetic (PK) and Pharmacokinetic/Pharmacodynamic (PK/PD) Target Attainment Analyses for Dalbavancin in Pediatric Patients
  12. 1412
    “…DISCLOSURES: Chloe Buzz, BS, Adjuvance Technologies (Employee) Eric Farris, PhD, Adjuvance Technologies (Employee) Sean R. Bennett, MD PhD, Adjuvance Technologies (Employee) Pat Frenchick, PhD, Adjuvance Technologies (Consultant) Tyler Martin, MD, Adjuvance Technologies (Employee, Shareholder)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1237. Robust Adjuvant Activity and Dose-sparing Potential of the Novel Semisynthetic Saponin Adjuvant TQL1055 for Seasonal and Pandemic Influenza
  13. 1413
    “…DISCLOSURES: Alita Miller, PhD, Entasis Therapeutics (Employee) Sarah McLeod, PhD, Entasis Therapeutics (Employee) Samir Moussa, PhD, Entasis Therapeutics (Employee)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1293. Sulbactam-durlobactam is active against recent, multi-drug resistant Acinetobacter baumannii clinical isolates from the Middle East
  14. 1414
    “…DISCLOSURES: Sarah McLeod, PhD, Entasis Therapeutics (Employee) Samir Moussa, PhD, Entasis Therapeutics (Employee) Alita Miller, PhD, Entasis Therapeutics (Employee)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1254. In vitro activity of sulbactam-durlobactam against recent global clinical Acinetobacter baumannii-calcoaceticus complex isolates
  15. 1415
    “…DISCLOSURES: Cristina Carias, PhD, Merck (Employee, Shareholder) Tianyan Hu, PhD, Merck (Employee, Shareholder) Ya-Ting Chen, PhD, Merck & Co., Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1379. Caregiver Burden related to Rotavirus Gastroenteritis: a systematic literature review
  16. 1416
    “…Both male and female students ranging from BS to PhD programs were the focus of the research. METHODS: Quantitative data was collected through survey method using stratified random sampling technique. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Adolescent health literacy: factors effecting usage and expertise of digital health literacy among universities students in Pakistan
  17. 1417
    “…Sahm, PhD, IHMA (Employee)Pfizer, Inc. (Independent Contractor)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1293. In vitro Activity of Ceftibuten in Combination with VNRX-5236 against Clinical Isolates of Enterobacterales from Urinary Tract Infections Collected in 2018-2020
  18. 1418
    “…DISCLOSURES: David Huang, MD, PhD, Lysovant (Consultant) Eric Gaukel, BS, Lysovant (Employee) Katyna Borroto-Esoda, PhD, Lysovant (Consultant) Arnold Bayer, MD, PhD, Lysovant (Grant/Research Support)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1071. Efficacy of Anti-Staphylococcal Lysin, LSVT-1701, in Combination with Daptomycin in Experimental Left-Sided Infective Endocarditis (IE) Due to Methicillin-Resistant Staphylococcus aureus (MRSA)
  19. 1419
    “…DISCLOSURES: Meredith Hackel, PhD MPH, IHMA (Employee)Pfizer, Inc. (Independent Contractor) Gregory Stone, PhD, AztraZeneca (Shareholder, Former Employee)Pfizer, Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1224. In vitro Activities of Ceftaroline and Comparator Agents against Gram-positive Bacterial Pathogens Causing Blood Stream Infections in a Global Population: ATLAS Surveillance Program 2012-2019
  20. 1420
    “…Sahm, PhD, IHMA (Employee)Pfizer, Inc. (Independent Contractor)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1253. Antimicrobial Activity of Cefepime in Combination with Taniborbactam Against Clinical Isolates of Enterobacterales from 2018-2020 Global Surveillance
Herramientas de búsqueda: RSS